Contraception clinical trials at UCSF

3 in progress, 1 open to eligible people

Contraception prevents pregnancy. UCSF is researching if more information about permanent birth control, like tubal sterilization, helps people who do not want more children. They are also studying how well people understand their options for long-term contraception.

Showing trials for

  • Patient-centered Information on Permanent Contraception

    open to eligible females ages 21-45

    The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives. Participants will: - Complete a baseline survey - Receive access to web-based educational resources - Complete a brief follow up survey immediately after exploring these web-based resources - Complete a follow-up survey 3 months after enrolling The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.

    San Francisco, California

  • Ulipristal Acetate (UPA) Used Daily as a Contraceptive

    Sorry, currently not accepting new patients, but might later

    This is a Phase IIb multicenter, open-label, non-comparative trial of continuous daily oral 10 mg of ulipristal acetate (UPA) to evaluate its contraceptive efficacy as the primary method of contraception.

    San Francisco, California and other locations

  • UCSF College Health Study on Contraceptive Training and Education at Community Colleges

    Sorry, in progress, not accepting new patients

    The purpose of this study is to measure whether a training and education intervention for clinic staff and young women aged 18-25 on contraceptive methods, including intrauterine devices (IUDs) and the implant, will result in greater contraceptive knowledge and access among students in community colleges.

    San Francisco, California

Our lead scientists for Contraception research studies include .